Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) fell 4.8% on Monday . The stock traded as low as $5.00 and last traded at $5.00. 37,721 shares were traded during trading, a decline of 93% from the average session volume of 532,882 shares. The stock had previously closed at $5.25.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the stock. StockNews.com assumed coverage on shares of Veradigm in a report on Monday. They issued a "hold" rating on the stock. Stephens boosted their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a report on Friday, January 31st.
Read Our Latest Report on Veradigm
Veradigm Price Performance
The firm's fifty day moving average is $6.18 and its 200-day moving average is $8.54.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
